Barusiban
- Generic Name
- Barusiban
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C40H63N9O8S
- CAS Number
- 285571-64-4
- Unique Ingredient Identifier
- UX33I93GLS
- Background
Barusiban has been used in trials studying the treatment of Infertility and In Vitro Fertilisation (IVF) Treatment.
- Associated Conditions
- -
- Associated Therapies
- -
Effect of Oxytocin Antagonist on Reduction of Uterine Contractions
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-01-06
- Last Posted Date
- 2017-06-21
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 99
- Registration Number
- NCT01043120
- Locations
- 🇪🇸
IVI Madrid, Madrid, Spain
🇪🇸IU Dexeus, Barcelona, Spain
🇨🇿IVF Institute, Plzen, Czechia
Effect of Oxytocin and Vasopressin Antagonists on Uterine Contractions
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-01-07
- Last Posted Date
- 2017-06-21
- Lead Sponsor
- Ferring Pharmaceuticals
- Target Recruit Count
- 125
- Registration Number
- NCT00587327
- Locations
- 🇪🇸
Institut Universitari Dexeus, Barcelona, Spain
🇪🇸IVI Madrid, Madrid, Spain
🇨🇿Institute for Reproductive Medicine and Endocrinology, Pilsen, Czechia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath